ENDRA Life Sciences (NDRA) Asset Utilization Ratio (2017 - 2018)
ENDRA Life Sciences (NDRA) posted quarterly Asset Utilization Ratio of 0.0 for Q4 2018, down 97.19% year-over-year from 0.05 in Q4 2017, and down 75.85% quarter-over-quarter from 0.01 in Q3 2018.
ENDRA Life Sciences (NDRA) Asset Utilization Ratio (2017 - 2018) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Asset Utilization Ratio for 2 consecutive years, with 0.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Asset Utilization Ratio fell 97.19% year-over-year to 0.0; the TTM figure through Dec 2018 stood at 0.0 (down 97.19% YoY), while the FY2018 annual figure was 0.0, down 99.13% from the prior year.
- Asset Utilization Ratio eased to 0.0 in Q4 2018 per NDRA's latest filing, from 0.01 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.14 in Q2 2017 and bottomed at 0.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 0.41 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 0.29 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1.33 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 0.56 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 0.57 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 0.68 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 1.13 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 0.69 |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 0.00 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.09 |
| Mar 31, 2018 | 0.07 |
| Dec 31, 2017 | 0.05 |
| Sep 30, 2017 | 0.11 |
| Jun 30, 2017 | 0.14 |